These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. The effect of eight half-yearly single-dose treatments with DEC on Wuchereria bancrofti circulating antigenaemia. Simonsen PE, Magesa SM, Meyrowitsch DW, Malecela-Lazaro MN, Rwegoshora RT, Jaoko WG, Michael E. Trans R Soc Trop Med Hyg; 2005 Jul; 99(7):541-7. PubMed ID: 15869771 [Abstract] [Full Text] [Related]
9. Wuchereria bancrofti antigenemia clearance among Myanmar migrants after biannual mass treatments with diethylcarbamazine, 300 mg oral-dose FILADEC tablet, in Southern Thailand. Koyadun S, Bhumiratana A, Prikchu P. Southeast Asian J Trop Med Public Health; 2003 Dec; 34(4):758-67. PubMed ID: 15115084 [Abstract] [Full Text] [Related]
12. The effect of repeated half-yearly diethylcarbamazine mass treatment on Wuchereria bancrofti infection and transmission in two East African communities with different levels of endemicity. Simonsen PE, Meyrowitsch DW, Mukoko DA, Pedersen EM, Malecela-Lazaro MN, Rwegoshora RT, Ouma JH, Masese N, Jaoko WG, Michael E. Am J Trop Med Hyg; 2004 Jan; 70(1):63-71. PubMed ID: 14971700 [Abstract] [Full Text] [Related]
18. Effect of annual mass administration of diethylcarbamazine and albendazole on bancroftian filariasis in five villages in south India. Ramaiah KD, Vanamail P, Yuvaraj J, Das PK. Trans R Soc Trop Med Hyg; 2011 Aug; 105(8):431-7. PubMed ID: 21601901 [Abstract] [Full Text] [Related]
19. Immunomonitoring of filarial patients during DEC therapy in an endemic area: a seven-year follow-up. Padigel UM, Reddy MV, Alikhan A, Harinath BC. J Trop Med Hyg; 1995 Feb; 98(1):52-6. PubMed ID: 7861480 [Abstract] [Full Text] [Related]